Vortuzi 500mg Rituximab Injection

Vortuzi 500mg Rituximab Injection is a prescription biologic medication used in the treatment of certain blood cancers and autoimmune disorders, including non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, and other conditions associated with abnormal B-cell activity. It contains Rituximab, a monoclonal antibody that targets the CD20 protein on B lymphocytes, helping the immune system identify and eliminate these cells. By reducing abnormal or overactive B cells, Vortuzi 500mg Rituximab Injection helps control disease progression and improve treatment outcomes. Administered as an intravenous infusion under the supervision of a healthcare professional, it requires regular monitoring to assess treatment effectiveness and manage potential infusion-related reactions and other side effects. Patients should use Vortuzi 500mg Rituximab Injection only as prescribed by their healthcare provider.